<DOC>
	<DOCNO>NCT00977717</DOCNO>
	<brief_summary>In order explore genetic factor may determine neurotoxicity oxaliplatin-based chemotherapy , germinal gene polymorphism analyze .</brief_summary>
	<brief_title>Pharmacogenomic Study Predict Neurotoxicity Oxaliplatin</brief_title>
	<detailed_description>To investigate impact single nucleotide ( SNP ) polymorphism toxicity profile colorectal cancer patient treat FOLFOX chemotherapy , 10 cc blood drawn EDTA tube extraction . DNA extract peripheral blood sample use DNA isolation kit , SNP polymorphisms evaluate .</detailed_description>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>age 18 older curatively resect colon adenocarcinoma pathologically stag III adequate performance status adequate major organ function treat adjuvant FOLFOX chemotherapy write informed consent disagree study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>oxaliplatin</keyword>
	<keyword>neuropathy</keyword>
	<keyword>SNPs</keyword>
</DOC>